1 min de lecture
[Press Release] XAV19 : validation of the first dose of anti-Covid treatment of XENOTHERA
-
-
Auteurcontact@xenothera.com
-
Publié12 novembre 2020
Articles récents
[Press Alert] XENOTHERA announces the efficacy of its XAV-19 antibody against the BQ.1.1variant.
December 19, 2022. # Download our press alert (english version) # Télécharger...
More[Press Release] XAV-19: end of EUROXAV clinical trial and positive trends for the XENOTHERA antibody.
December 16,2022. # Download our press release (english version) # Télécharger notre...
More[Newsletter] XENONEWS
November 2022. >> Official XENOTHERA’s newsletter /Lettre d’information officielle de XENOTHERA <<...
More